TMS vs Ketamine

When it comes to treating depression that hasn’t responded to traditional methods, two innovative options often come up: transcranial magnetic stimulation (TMS) and ketamine therapy. While both are used for similar conditions, they work in very different ways — one using targeted magnetic pulses to stimulate specific areas of the brain, the other relying on a fast-acting medication to create shifts in brain chemistry. Understanding how each treatment works, what to expect, and who may benefit most can help clarify which approach might be the right fit.

Home > About us > Blog > TMS vs Ketamine

Table Of Contents

01 -

What Is TMS Therapy?

02 -

What Is Ketamine Therapy?

03 -

Key Differences Between TMS and Ketamine Treatment

04 -

Summary of Differences: TMS vs Intravenous Ketamine

05 -

Which Option Is the Best for Depression Treatment?

06 -

Factors to Consider When Choosing Between TMS and Ketamine Infusion Therapy

07 -

Should You Consider a Combined Treatment (TMS + IV Ketamine)?

08 -

Mindset TMS Offers Professional Brain Stimulation Therapy in Greeley, CO

09-

Conclusion

What Is TMS Therapy?

TMS is a non-invasive procedure that uses magnetic pulses to stimulate brain areas involved in mood regulation. It’s FDA-approved for depression and other mental health conditions, especially when medications haven’t worked. Sessions are typically done in-office and require no anesthesia or downtime.

What Is Ketamine Therapy?

This treatment involves using a low dose of ketamine, often administered through an intravenous (IV) line or as an esketamine nasal spray, to relieve symptoms of depression rapidly. Unlike traditional antidepressants, it acts on the brain’s glutamate system to promote new neural connections. Esketamine nasal spray is FDA-approved for treatment-resistant depression and must be given under medical supervision.

Key Differences Between TMS and Ketamine Treatment

Mechanism of Action

TMS treatment and ketamine therapy affect the brain in different ways. TMS uses magnetic fields to stimulate nerve cells in regions responsible for mood control, gradually enhancing communication between these areas. In contrast, ketamine rapidly influences glutamate activity, triggering a cascade of changes in nerve cells that can quickly improve mood and cognition.

Conditions Treated

Both TMS and ketamine therapy are used to treat mental health disorders, but they’re not identical in scope. TMS is most commonly utilized for major depressive disorder and OCD, with a promising potential for alleviating PTSD, anxiety, bipolar disorder, autism, and ADHD. Ketamine is approved for treatment-resistant depression and is sometimes used off-label for PTSD and bipolar depression under close medical supervision.

Timeline for Results

Treatment duration and speed of response differ significantly between the two. TMS typically requires daily sessions over several weeks, with gradual improvement in depressive symptoms as the brain adjusts. Ketamine often produces noticeable relief within hours or days, though multiple sessions are usually needed for lasting effects.

Duration of Effects

The lasting impact of each treatment can vary depending on the individual and the severity of the condition. TMS has been shown to produce long-term benefits for many individuals with major depressive disorder, especially with maintenance sessions. Ketamine’s effects tend to be shorter-lived, and patients may need ongoing or booster treatments to maintain progress.

Side Effects and Safety Considerations

TMS and ketamine have different safety profiles based on clinical trials and patient experiences. TMS is generally well-tolerated and does not carry the systemic side effects associated with traditional antidepressant medications. Ketamine may cause dissociation, nausea, and increased blood pressure during sessions, and there’s ongoing research into its long-term safety with repeated use

Setting and Frequency of Treatments

TMS is performed in a clinic using repetitive transcranial magnetic stimulation (rTMS), Deep TMS, or the newer intermittent theta burst stimulation (iTBS), with daily sessions lasting between 3 and 40 minutes for several weeks. Ketamine is administered under supervision in a medical setting through IV infusion or as an esketamine nasal spray, typically once or twice a week in the initial phase. Both require consistent follow-up for monitoring and potential maintenance therapy.

Insurance Coverage and Cost

Insurance coverage can differ widely between the two options. TMS treatment is FDA-approved and often reimbursed by insurance for depression after other options have failed, though preauthorization is usually required. Ketamine therapy, especially IV infusions, is frequently not covered by insurance, although esketamine nasal spray may be included in specific mental health plans.

Summary of Differences: TMS vs Intravenous Ketamine

TMS

IV Ketamine

Mechanism of Action

Magnetic pulses stimulate nerve cells in mood centers

Alters glutamate activity to impact nerve cells

FDA Approval

Yes, for major depressive disorder

No (off-label use); esketamine nasal spray is FDA approved

Conditions Treated

Major depressive disorder, OCD, anxiety, smoking addiction, PTSD

Treatment-resistant depression, PTSD (off-label)

Timeline for Results

Gradual improvement over several weeks

Often within hours or days

Duration of Effects

Can be long-lasting with maintenance

Shorter-lasting; may require regular boosters

Side Effects

Mild headache or scalp discomfort

Dissociation, nausea, increased blood pressure

Safety Profile

Non-invasive, minimal systemic effects

Requires careful monitoring; long-term effects still being studied

Treatment Setting

Outpatient clinic; no anesthesia

Medical facility

Frequency of Treatments

Daily sessions (Monday to Friday) for 1–6 weeks (rTMS, dTMS, or iTBS)

Typically 1–2 times per week initially

Insurance Coverage

Often covered with prior authorization

Usually not covered; esketamine may be

Cost (Without Insurance)

$100–$500 per session (may be covered)

$400–$800+ per infusion (often out-of-pocket)

TMS

IV Ketamine

Mechanism of Action

Magnetic pulses stimulate nerve cells in mood centers

Mechanism of Action

Alters glutamate activity to impact nerve cells

FDA Approval

Yes, for major depressive disorder

FDA Approval

No (off-label use); esketamine nasal spray is FDA approved

Conditions Treated

Major depressive disorder, OCD, anxiety, smoking addiction, PTSD

Conditions Treated

Treatment-resistant depression, PTSD (off-label)

Timeline for Results

Gradual improvement over several weeks

Timeline for Results

Often within hours or days

Duration of Effects

Can be long-lasting with maintenance

Duration of Effects

Shorter-lasting; may require regular boosters

Side Effects

Mild headache or scalp discomfort

Side Effects

Dissociation, nausea, increased blood pressure

Safety Profile

Non-invasive, minimal systemic effects

Safety Profile

Requires careful monitoring; long-term effects still being studied

Treatment Setting

Outpatient clinic; no anesthesia

Treatment Setting

Medical facility

Frequency of Treatments

Daily sessions (Monday to Friday) for 1–6 weeks (rTMS, dTMS, or iTBS)

Frequency of Treatments

Typically 1–2 times per week initially

Insurance Coverage

Often covered with prior authorization

Insurance Coverage

Usually not covered; esketamine may be

Cost (Without Insurance)

$100–$500 per session (may be covered)

Cost (Without Insurance)

$400–$800+ per infusion (often out-of-pocket)

Which Option Is the Best for Depression Treatment?

When deciding between TMS and ketamine for depression treatment, the best option often depends on individual needs, medical history, and treatment goals. Both therapies have shown strong potential for symptom reduction in people with treatment-resistant depression. Still, TMS is generally preferred for those seeking a non-invasive, medication-free approach with long-term benefits. With its strong safety profile, gradual and sustained effects, and FDA approval for major depressive disorder, TMS offers a reliable path to recovery for many patients without the dissociative side effects associated with ketamine.

Factors to Consider When Choosing Between TMS and Ketamine Infusion Therapy

Medical History

Your medical history plays a significant role in determining whether TMS or ketamine infusion therapy is the better fit. Individuals with a history of seizures or magnetic-sensitive metal implants in or 12 inches near the head may not be suitable candidates for TMS. On the other hand, ketamine should be avoided in those with uncontrolled high blood pressure, a history of substance misuse, or certain heart conditions, as its dissociative effects and cardiovascular impact can pose risks.

Accessibility

TMS’s dramatically improved tolerability and convenience make it substantially more acceptable to many individuals with MDD. This therapy requires no anesthesia, pre-procedure fasting, monitoring, or transportation assistance. Patients can drive themselves to and from treatments and immediately resume normal activities. Each session typically lasts 20-40 minutes, fitting more easily into busy schedules than ECT, which requires substantial preparation and recovery time. This convenience factor significantly improves treatment adherence, as patients are more likely to complete the entire course of therapy when it minimally disrupts their daily lives. For individuals who cannot pause their responsibilities, such as childcare, work obligations, or educational commitments, TMS provides a way to address MDD without surrendering these critical functions.

Personal Preferences

Personal comfort with the type of mental health treatment can also guide the decision. Some individuals may prefer the gradual, non-invasive approach of TMS, especially if they’ve had negative experiences with medication. Others choose the rapid effects of ketamine, particularly if they’re looking for quicker symptom relief and are open to a medication-based therapy.

Presence of Complications, Such as Bipolar Disorder

Comorbid conditions like bipolar disorder must be carefully considered when choosing a treatment path. TMS may be appropriate for bipolar depression under medical supervision, but it is typically used with caution to avoid triggering mania. Ketamine therapy, while sometimes used off-label in bipolar depression, also carries a risk of mood destabilization, making a thorough psychiatric evaluation essential before starting treatment.

Should You Consider a Combined Treatment (TMS + IV Ketamine)?

In some cases, a combined treatment of TMS and IV ketamine may offer enhanced benefits, especially for individuals with severe or treatment-resistant depression. While TMS works gradually by stimulating brain areas involved in mood regulation, ketamine can provide rapid symptom relief by targeting different neurotransmitter systems. Combining these treatments may offer a more comprehensive approach for patients who do not experience complete symptom reduction from one therapy alone. However, this strategy requires careful coordination between healthcare providers to ensure treatment safety and optimal timing. If considering a combined approach, discussing the potential benefits and risks with a qualified mental health professional is essential.

Mindset TMS Offers Professional Brain Stimulation Therapy in Greeley, CO

Mindset TMS provides professional brain stimulation therapy in Greeley, CO, offering non-invasive treatments for individuals struggling with treatment-resistant depression and other mental health conditions. Using FDA-approved TMS protocols, our experienced team works closely with patients to develop personalized treatment plans to improve mood and overall well-being. With a focus on providing compassionate care in a comfortable setting, Mindset TMS offers a proven alternative to traditional therapies, helping patients take the next step toward lasting mental health recovery.

Conclusion

Both TMS and ketamine infusion therapy offer promising alternatives for individuals with treatment-resistant depression, providing unique benefits and requiring specific considerations. While TMS is a non-invasive, FDA-approved option that delivers gradual, long-lasting symptom relief, ketamine offers rapid effects with the potential for significant improvement. For those exploring all treatment options, electroconvulsive therapy may also be considered for severe cases, although it typically involves more substantial side effects and a longer recovery process. Ultimately, the best approach depends on personal preferences, medical history, and treatment goals. Consulting with a mental health professional is key to determining the most appropriate therapy to achieve the best outcomes for your mental health.